5-methylcytosine has been researched along with Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanno, H; Nakazawa, K; Ohya, M | 1 |
| Bell, WC; Frost, AR; Grizzle, WE; Heimburger, DC; Johanning, GL; Niveleau, A; Oelschlager, D; Piyathilake, CJ; Weiss, H | 1 |
2 other study(ies) available for 5-methylcytosine and Hyperplasia
| Article | Year |
|---|---|
Lower number of 5-hydroxymethylcytosine-expressing cells in plasma cell myeloma than in reactive plasma cell hyperplasia: a useful immunohistochemical approach for identification of neoplastic plasma cells.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Humans; Hyperplasia; Immunohistochemistry; Male; Middle Aged; Multiple Myeloma; Plasma Cells | 2019 |
Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression.
Topics: 5-Methylcytosine; Antibodies, Monoclonal; Bronchi; Carcinoma, Squamous Cell; Cytosine; Disease Progression; Disease Susceptibility; DNA Methylation; DNA, Neoplasm; Fluorescent Antibody Technique, Indirect; Genetic Predisposition to Disease; Humans; Hyperplasia; Lung Neoplasms; Precancerous Conditions; Respiratory Mucosa; Smoking | 2001 |